| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/12/2006 | US7148190 Haptotactic peprides |
| 12/12/2006 | US7148028 For diagnosis, prognosis, prophylaxis |
| 12/12/2006 | US7147877 Method for treating lesions caused by estrogen deficiency with extract of cucumber |
| 12/12/2006 | US7147849 Including compatible solute; enhancing effectiveness of protein containing active material; reducing cytotoxic activity |
| 12/12/2006 | CA2451725C Therapeutic combinations for the treatment of hormone deficiencies |
| 12/12/2006 | CA2347741C Thiazole-derivatives |
| 12/12/2006 | CA2342206C Microparticles |
| 12/12/2006 | CA2268314C Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems |
| 12/12/2006 | CA2190851C Palladium catalyzed ring closure of triazolyl tryptamine |
| 12/12/2006 | CA2140106C Method of treating hyperproliferative vascular disease |
| 12/12/2006 | CA2098176C Angiotensin ii receptor blocking compositions |
| 12/07/2006 | WO2006130174A2 Compositions comrising nebivolol |
| 12/07/2006 | WO2006130090A1 Use of a substance which inhibits endothelin type b and 5-hydroxytryptamine type 1b receptor upregulation in the treatment of ischemic disorders |
| 12/07/2006 | WO2006129826A1 Novel piperidine derivative |
| 12/07/2006 | WO2006129788A1 Agent for regeneration and/or protection of nerves |
| 12/07/2006 | WO2006129785A1 Concomitant pharmaceutical agents and use thereof |
| 12/07/2006 | WO2006129784A1 INTERFERON-α REGULATOR |
| 12/07/2006 | WO2006129755A1 Therapeutic agent for blood-related disease containing epo derivative |
| 12/07/2006 | WO2006129679A1 Spiropiperidine compound and medicinal use thereof |
| 12/07/2006 | WO2006129649A1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof |
| 12/07/2006 | WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative |
| 12/07/2006 | WO2006129524A1 Carbonyl compound remover |
| 12/07/2006 | WO2006129468A1 Process for preparation of granular oral composition using oligosaccharide solution |
| 12/07/2006 | WO2006129353A1 Novel agent for suppressing blood pressure elevation |
| 12/07/2006 | WO2006128853A1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 12/07/2006 | WO2006128847A2 Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor |
| 12/07/2006 | WO2006128600A2 Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine |
| 12/07/2006 | WO2006128293A1 Kinin b1 receptor peptide agonists and uses thereof |
| 12/07/2006 | WO2006128253A1 Delivery systems |
| 12/07/2006 | WO2006078606A3 Ati receptor antagonists for treating vascular inflammation |
| 12/07/2006 | US20060276854 Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the BBB and cerebral blood flow |
| 12/07/2006 | US20060276659 Process for preparation of perindopril and salts thereof |
| 12/07/2006 | US20060276645 Novel carboxylic acid derivatives, their preparation and use |
| 12/07/2006 | US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 12/07/2006 | US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38 |
| 12/07/2006 | US20060276497 Novel multicyclic compounds and the use thereof |
| 12/07/2006 | US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 12/07/2006 | US20060276486 Lklf/klf2 gene expression promoter |
| 12/07/2006 | US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid |
| 12/07/2006 | US20060276474 Novel carboxylic acid derivatives, their preparation and use |
| 12/07/2006 | US20060276449 depression, anxiety, neurodegenerative disorders, eating disorders, hypertension, gastrointestinal/immunological diseases, drug dependence, epilepsy, cerebral infarction/ischemia/edema, head trauma, inflammation, alopecia; arginine-vasopressin V1b receptor antagonists; metabolic stability |
| 12/07/2006 | US20060276432 Lipid-regulating agent and use thereof |
| 12/07/2006 | US20060276427 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/07/2006 | US20060276421 single-stranded oligonucleotide comprising a 5'-end sequence, an intermediate sequence and a 3'-end sequence, both ends having reverse complementarity with the intermediate sequence, intermediate sequence having loops at both ends; phosphate groups are not phosphorothioated; antiinflammatory agent |
| 12/07/2006 | US20060276415 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 12/07/2006 | US20060276397 Crystallization of IGF-1 |
| 12/07/2006 | US20060276384 Peptides and medicinal compositions containing the same |
| 12/07/2006 | US20060275791 Biological control of nanoparticle nucleation, shape and crystal phase |
| 12/07/2006 | US20060275770 Heart failure gene determination and therapeutic screening |
| 12/07/2006 | US20060275359 Palliative effects of morinda citrifolia oil and juice |
| 12/07/2006 | US20060275287 Scroll compressor |
| 12/07/2006 | US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination |
| 12/07/2006 | US20060273819 Antibiotic tetrahydro-beta-carboline derivatives |
| 12/07/2006 | CA2610782A1 Epo derivative-containing therapeutic agents for blood-related diseases |
| 12/07/2006 | CA2610694A1 Compositions comrising nebivolol |
| 12/07/2006 | CA2610692A1 Ep2 agonists which may have an ep3 agonistic effect for regeneration and/or protection of nerves |
| 12/07/2006 | CA2609429A1 Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor |
| 12/07/2006 | CA2609388A1 Novel piperidine derivative |
| 12/07/2006 | CA2609355A1 Organic compounds |
| 12/07/2006 | CA2609352A1 Delivery systems |
| 12/07/2006 | CA2608916A1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 12/07/2006 | CA2608212A1 Novel piperidine carboxylic acid amide derivatives |
| 12/06/2006 | EP1728794A1 Maleate addition salt of hydropyridine derivatives |
| 12/06/2006 | EP1728532A1 Method and system for myocardial infarction repair |
| 12/06/2006 | EP1728516A1 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 12/06/2006 | EP1728507A1 Compositions for treating or preventing cardiovascular disease |
| 12/06/2006 | EP1728504A1 Emulsion stabilizer |
| 12/06/2006 | EP1727555A1 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 12/06/2006 | EP1727546A2 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad |
| 12/06/2006 | EP1456212B1 6-aminomorphinane derivatives, method for the production and use thereof |
| 12/06/2006 | EP1368319B1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 12/06/2006 | EP1318977B1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof |
| 12/06/2006 | EP1313459B1 Polycyclic dianthraquinones as anti-cancer and anti-angiogenic agents |
| 12/06/2006 | EP1291343B1 Hydroxyformamidine derivatives and medicines containing the same |
| 12/06/2006 | EP1218381B1 AMINO SUBSTITUTED PYRAZOLO¬1,5-a|-1,5-PYRIMIDINES AND PYRAZOLO¬1,5-a|-1,3,5-TRIAZINES |
| 12/06/2006 | EP1078001B1 Il-6 antagonist peptides |
| 12/06/2006 | EP0983346B1 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 12/06/2006 | EP0837934B1 Human vascular endothelial growth factor 2 |
| 12/06/2006 | EP0740701B1 Mammalian monocyte chemoattractant protein receptors |
| 12/06/2006 | CN1875030A Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases |
| 12/06/2006 | CN1874778A Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer |
| 12/06/2006 | CN1874765A Accelerator for initial insulin secretion |
| 12/06/2006 | CN1872997A New technique for culturing stem cells (carrying therapy gene) of human's xenogenic stromata in large-scale |
| 12/06/2006 | CN1872879A Anagonism active polypeptide of CXCR4 acceptor from inflammation protein of virus macrophage |
| 12/06/2006 | CN1872840A Ozagrel lysine, preparing method and usage |
| 12/06/2006 | CN1872344A Gene therapy method of stem cell (carrying therapy gene) of human xenogenic stroma |
| 12/06/2006 | CN1872342A Process for preparation of granular oral composition using oligosaccharide solution |
| 12/06/2006 | CN1872329A Application of medication composition of containing giant gen-seng in preparing medicine for treating insufficiency of blood supply for brain |
| 12/06/2006 | CN1872328A Application of medication composition of containing giant typhonium tuber in preparing medicine for treating insufficiency of blood supply for brain |
| 12/06/2006 | CN1872326A Composition of external remedy for treating hemorrhoids, and preparation method |
| 12/06/2006 | CN1872320A Drop pills of medication for supplying body fluids and reinforce qi, promoting blood flow and activating the channels, and preparation method |
| 12/06/2006 | CN1872319A Application of medication composition of containing polygala root in preparing medicine for treating insufficiency of blood supply for brain |
| 12/06/2006 | CN1872317A Application of medication of containing red sage root in resistant medication anti aspirin |
| 12/06/2006 | CN1872316A Medication of containing astragalus root in application for treating resistant medication of aspirin |
| 12/06/2006 | CN1872315A Application of medication of containing spatholobus stem in resistant medication anti aspirin |
| 12/06/2006 | CN1872314A Application of medication of containing spatholobus stem in resistant medication anti aspirin |
| 12/06/2006 | CN1872313A Medication of containing curcuma root in application for treating resistant medication of aspirin |
| 12/06/2006 | CN1872312A Application of medication of containing red sage root in resistant medication anti aspirin |
| 12/06/2006 | CN1872311A Application of medication of containing red sage root in resistant medication anti aspirin |
| 12/06/2006 | CN1872305A Application of medication composition of containing Gardenia in preparing medicine for treating insufficiency of blood supply for brain |